Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Aug 2022 for Epizyme, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Carol Stuckley: trading record in brief
Carol Stuckley (board member) discloses dealings in Epizyme, Inc. to SEC (Form 4). Over a trading history stretching from 16 November 2021 to 12 August 2022, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 16 August 2022: a transaction, in Epizyme, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carol Stuckley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
25,696 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028856:0
8,994 shares0Common Stock, par value $0.0001SEC:0000899243-22-018839:0
16,702 shares0Common Stock, par value $0.0001SEC:0000899243-21-045210:0
3 of 3 declarations
